Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.

Saved in:
Bibliographic Details
Title: Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
Authors: Vincenzetti L; Vir Biotechnology, Bellinzona, Switzerland., Wong R; Vir Biotechnology, San Francisco, California, USA., Marzi R; Vir Biotechnology, Bellinzona, Switzerland., Guarino B; Vir Biotechnology, Bellinzona, Switzerland., Stefanutti E; Vir Biotechnology, San Francisco, California, USA., Gupta SV; Vir Biotechnology, San Francisco, California, USA., Rosen LE; Vir Biotechnology, San Francisco, California, USA., Belnap DM; School of Biological Sciences and Department of Biochemistry, University of Utah, Utah, USA., Wang L; Vir Biotechnology, San Francisco, California, USA., Chen YP; Vir Biotechnology, San Francisco, California, USA., di Iulio J; Vir Biotechnology, San Francisco, California, USA., Momin A; Vir Biotechnology, San Francisco, California, USA., Tracy KE; Vir Biotechnology, San Francisco, California, USA., Deshpande S; Vir Biotechnology, San Francisco, California, USA., Errico JM; Vir Biotechnology, San Francisco, California, USA., Giovannoni F; Vir Biotechnology, Bellinzona, Switzerland., Sprugasci N; Vir Biotechnology, Bellinzona, Switzerland., Peter A; Vir Biotechnology, Bellinzona, Switzerland., Seu L; Vir Biotechnology, San Francisco, California, USA., Cloutier D; Vir Biotechnology, San Francisco, California, USA., Tay CH; Vir Biotechnology, San Francisco, California, USA., Snell G; Vir Biotechnology, San Francisco, California, USA., Czudnochowski N; Vir Biotechnology, San Francisco, California, USA., Lempp FA; Vir Biotechnology, Bellinzona, Switzerland; Vir Biotechnology, San Francisco, California, USA., Havenar-Daughton C; Vir Biotechnology, San Francisco, California, USA., Benigni F; Vir Biotechnology, Bellinzona, Switzerland., Lanzavecchia A; Vir Biotechnology, Bellinzona, Switzerland., Agarwal K; Institute of Liver Studies, King's College Hospital, London, UK., Yuen MF; Department of Medicine, Queen Mary Hospital, University of Hong Kong, China., Wedemeyer H; Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Germany., Gane E; Faculty of Medicine, University of Auckland, New Zealand., Arvin A; Vir Biotechnology, San Francisco, California, USA., Corti D; Vir Biotechnology, Bellinzona, Switzerland., Schmid MA; Vir Biotechnology, Bellinzona, Switzerland. Electronic address: mschmid@vir.bio.
Source: Journal of hepatology [J Hepatol] 2026 Jan; Vol. 84 (1), pp. 62-73. Date of Electronic Publication: 2025 Aug 27.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-0641
DOI:10.1016/j.jhep.2025.08.016